Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer
出版年份 2014 全文链接
标题
Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 32, Issue 35, Pages 4012-4019
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2014-11-11
DOI
10.1200/jco.2013.54.5392
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Topotecan/cisplatin (TP) compared to cisplatin/etoposide (PE) for patients with extensive disease-small cell lung cancer (ED- SCLC): Final results of a randomised phase III trial
- (2017) D. F. Heigener et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic polymorphisms of metabolizing enzymes and transporters correlate with pharmacokinetics (PK) and pharmacodynamics (PD) of amrubicin.
- (2017) Y. Makino et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).
- (2017) N. Nogami et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).
- (2017) T. Hirose et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy.
- (2017) T. Ciuleanu et al. JOURNAL OF CLINICAL ONCOLOGY
- C609T Polymorphism of NAD(P)H Quinone Oxidoreductase 1 As a Predictive Biomarker for Response to Amrubicin
- (2011) Osamu Takakuwa et al. Journal of Thoracic Oncology
- Phase II Study of Amrubicin As Second-Line Therapy in Patients With Platinum-Refractory Small-Cell Lung Cancer
- (2010) David S. Ettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Single-Agent Amrubicin or Topotecan as Second-Line Treatment in Patients With Small-Cell Lung Cancer Sensitive to First-Line Platinum-Based Chemotherapy
- (2010) Robert Jotte et al. JOURNAL OF CLINICAL ONCOLOGY
- Small Cell Lung Cancer: Are We Making Progress?
- (2009) Jonathan E. Dowell et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
- (2009) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
- (2009) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer
- (2009) Kyoichi Kaira et al. LUNG CANCER
- Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer
- (2008) Se Hoon Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402
- (2008) Akira Inoue et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started